Non-curative gastrectomy for advanced gastric cancer does not result in additional risk of postoperative morbidity compared to curative gastrectomy

被引:2
作者
Gertsen, Emma C. [1 ]
Brenkman, Hylke J. F. [1 ]
Goense, Lucas [1 ,2 ]
Mohammad, Nadia Haj [3 ]
Weusten, Bas L. A. [4 ]
van Hillegersberg, Richard [1 ]
Ruurda, Jelle P. [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands
[3] Univ Utrecht, Univ Med Ctr Utrecht, Dept Oncol, Utrecht, Netherlands
[4] Univ Utrecht, Univ Med Ctr Utrecht, Dept Gastroenterol, Utrecht, Netherlands
来源
SURGICAL ONCOLOGY-OXFORD | 2020年 / 35卷
关键词
Gastric cancer; Non-curative gastrectomy; Morbidity; Population-based; PALLIATIVE GASTRECTOMY; PRIMARY TUMOR; CHEMOTHERAPY; RESECTION; SURVIVAL; SYMPTOMS; OUTCOMES; IMPACT;
D O I
10.1016/j.suronc.2020.08.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-curative gastrectomy (nCG) for gastric cancer can be considered in selected cases to relieve symptoms. The aim of this study was to evaluate postoperative morbidity and mortality in patients who underwent nCG and compare these results with an intended curative gastrectomy (CG). Materials and methods: All patients who underwent both nCG and CG in the Netherlands were included from the Dutch Upper GI Cancer Audit (2011-2016). In this population-based cohort study postoperative morbidity, mortality, readmissions and short-term oncological outcomes were appraised. Propensity score matching (PSM) was applied to create comparable groups of patients who underwent nCG versus CG, using patient and tumor characteristics. Results: Of the 2202 eligible patients, 115 patients underwent nCG and 2087 underwent CG. After PSM, 115 nCGpatients were matched to 227 CG-patients. More conversions from laparoscopic to open surgery occurred during nCG (10.4 versus 2.6%, p = 0.007). Although postoperative mortality was higher after nCG in the original cohort (9.6 versus 4.8%, p = 0.026), after PSM there was no difference between groups (9.6 versus 7.0%, p = 0.415). Postoperative morbidity, re-interventions and readmission rates did not differ significantly between groups. Resection of additional organs (30.4 versus 11.5%, p < 0.001) and R+ resections (65.2 versus 12.3%, p < 0.001) occurred more frequently during nCG. Conclusions: nCG does not lead to additional postoperative risks compared to CG in patients with similar characteristics, and may be considered in fit patients with advanced gastric cancer. However, randomized trials evaluating potential (survival) benefits of nCG should be awaited.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 35 条
[1]   The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI [J].
Al-Batran, Salah-Eddin ;
Goetze, Thorsten O. ;
Mueller, Daniel W. ;
Vogel, Arndt ;
Winkler, Michael ;
Lorenzen, Sylvie ;
Novotny, Alexander ;
Pauligk, Claudia ;
Homann, Nils ;
Jungbluth, Thomas ;
Reissfelder, Christoph ;
Caca, Karel ;
Retter, Steffen ;
Horndasch, Eva ;
Gumpp, Julia ;
Bolling, Claus ;
Fuchs, Karl-Hermann ;
Blau, Wolfgang ;
Padberg, Winfried ;
Pohl, Michael ;
Wunsch, Andreas ;
Michl, Patrick ;
Mannes, Frank ;
Schwarzbach, Matthias ;
Schmalenberg, Harald ;
Hohaus, Michael ;
Scholz, Christian ;
Benckert, Christoph ;
Knorrenschild, Jorge Riera ;
Kanngiesser, Veit ;
Zander, Thomas ;
Alakus, Hakan ;
Hofheinz, Ralf-Dieter ;
Roedel, Claus ;
Shah, Manish A. ;
Sasako, Mitsuru ;
Lorenz, Dietmar ;
Izbicki, Jakob ;
Bechstein, Wolf O. ;
Lang, Hauke ;
Moenig, Stefan P. .
BMC CANCER, 2017, 17
[2]   Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer The AIO-FLOT3 Trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Illerhaus, Gerald ;
Martens, Uwe M. ;
Stoehlmacher, Jan ;
Schmalenberg, Harald ;
Luley, Kim B. ;
Prasnikar, Nicole ;
Egger, Matthias ;
Probst, Stephan ;
Messmann, Helmut ;
Moehler, Markus ;
Fischbach, Wolfgang ;
Hartmann, Joerg T. ;
Mayer, Frank ;
Hoeffkes, Heinz-Gert ;
Koenigsmann, Michael ;
Arnold, Dirk ;
Kraus, Thomas W. ;
Grimm, Kersten ;
Berkhoff, Stefan ;
Post, Stefan ;
Jager, Elke ;
Bechstein, Wolf ;
Ronellenfitsch, Ulrich ;
Moenig, Stefan ;
Hofheinz, Ralf D. .
JAMA ONCOLOGY, 2017, 3 (09) :1237-1244
[3]  
[Anonymous], 2016, DUTCH UPPER GI CANC
[4]   An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies [J].
Austin, Peter C. .
MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (03) :399-424
[5]  
Bonenkamp JJ, 2001, HEPATO-GASTROENTEROL, V48, P1219
[6]   Postoperative Outcomes of Minimally Invasive Gastrectomy Versus Open Gastrectomy During the Early Introduction of Minimally Invasive Gastrectomy in the Netherlands A Population-based Cohort Study [J].
Brenkman, Hylke J. F. ;
Gisbertz, Suzanne S. ;
Slaman, Annelijn E. ;
Goense, Lucas ;
Ruurda, Jelle P. ;
Henegouwen, Mark I. van Berge ;
van Hillegersberg, Richard .
ANNALS OF SURGERY, 2017, 266 (05) :831-838
[7]   Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit [J].
Busweiler, L. A. D. ;
Wijnhoven, B. P. L. ;
Henegouwen, M. I. van Berge ;
Henneman, D. ;
van Grieken, N. C. T. ;
Wouters, M. W. J. M. ;
van Hillegersberg, R. ;
van Sandick, J. W. .
BRITISH JOURNAL OF SURGERY, 2016, 103 (13) :1855-1863
[8]   GASTRIC-CARCINOMA WITH SYNCHRONOUS LIVER METASTASES - PALLIATIVE GASTRECTOMY OR NOT [J].
CHOW, LWC ;
LIM, BH ;
LEUNG, SYL ;
BRANICKI, FJ ;
GERTSCH, P .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1995, 65 (10) :719-723
[9]   Gastrectomy in Advanced Gastric Cancer Effectively Palliates Symptoms and May Improve Survival in Select Patients [J].
Collins, Amy ;
Hatzaras, Ioannis ;
Schmidt, Carl ;
Carruthers, Katherine ;
Melvin, W. Scott ;
Muscarella, Pete ;
Ellison, E. Christopher ;
Martin, Edward ;
Bloomston, Mark .
JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (03) :491-496
[10]   Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].
Cunningham, David ;
Starling, Naureen ;
Rao, Sheela ;
Iveson, Timothy ;
Nicolson, Marianne ;
Coxon, Fareeda ;
Middleton, Gary ;
Daniel, Francis ;
Oates, Jacqueline ;
Norman, Andrew Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46